Clinical Trial Update: Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension

View source ↗

Summary

This entry notes the completion of a post-marketing observational study in patients with pulmonary arterial hypertension sponsored by Eli Lilly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Eli Lilly and Company | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED